The variability in trial durations, ranging from 3 to 12 weeks across the included studies, and differences in the number of titration steps for each drug may further influence the reported incidence of gastrointestinal adverse events, particularly for agents like tirzepatide, where nausea risk escalates with higher doses (e.g., OR = 4.36, 95% CI: 3.425.61 at 10 mg) (Liu et al., 2025)
For breakfast, overnight oats are a lifesaver
While many online retailers claim to supply genuine medicines, they may be unregulated, provided without a genuine clinical consultation and potentially very dangerous
PLEASE NOTE: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment